MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,305,541 | +68.7% | 452,707 | +38.1% | 0.17% | +66.3% |
Q2 2023 | $8,480,652 | -32.6% | 327,818 | -37.4% | 0.10% | -40.9% |
Q1 2023 | $12,583,598 | +79.0% | 523,880 | +45.3% | 0.17% | +81.9% |
Q4 2022 | $7,031,544 | -6.2% | 360,592 | +1.0% | 0.09% | -10.5% |
Q3 2022 | $7,500,000 | – | 356,952 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |